Guy El Helou

Guy El Helou, MD

Assistant Professor Of Medicine

Department: MD-INFECTIOUS DISEASES
Business Phone: (352) 294-5481

About Guy El Helou

Dr. Guy El Helou is a clinical infectious disease physician with a special focus on infections in the transplant population.

Dr. El Helou graduated from Saint Joseph University School of Medicine in Beirut, Lebanon with his medical degree and Masters in Basic Sciences. Following that, he completed an internal medicine residency at Hotel-Dieu de France University Hospital in Beirutand and began an infectious disease fellowship He completed his fellowship at Wake Forest Baptist Medical Center in Winston-Salem, North Carolina. During this time, he conducted research projects on vectored immunoprophylaxis through the salivary glands and developed clinical interest in infections in the immunocompromised host, which led him to pursue a subspecialty in transplant infectious diseases at Mayo Clinic in Rochester, Minnesota.

Dr. El Helou is currently a clinical assistant professor with the University of Florida College of Medicine. Here, he takes care of patients who present with infectious complications mainly following solid organ transplantation. He has a special interest in cytomegalovirus, or CMV, fungal infections and nontuberculous mycobacteria.

Clinical Profile

Subspecialties
  • Infectious Disease
Areas of Interest
  • Cytomegalovirus (CMV) infection
  • Nontuberculous Mycobacteria

Research Profile

Areas of Interest
  • Cytomegalovirus
  • Cytomegalovirus
  • transplant infectious disease
Open Researcher and Contributor ID (ORCID)

0000-0001-8787-5624

Publications

2022
Hepatitis C virus and kidney transplantation: Recent trends and paradigm shifts.
Transplantation reviews (Orlando, Fla.). [DOI] 10.1016/j.trre.2021.100677. [PMID] 35063799.
2022
Infectious diseases compensation in the USA: the relative value.
The Lancet. Infectious diseases. [DOI] 10.1016/S1473-3099(22)00360-7. [PMID] 35716701.
2021
Absolute lymphocyte count as marker of cytomegalovirus and allograft rejection: Is there a “Safe Corridor” after kidney transplantation?
Transplant Infectious Disease. [DOI] 10.1111/tid.13489.
2021
Retrograde Parotid Gland Infusion through Stensen’s Duct in a Non-Human Primate for Vectored Gene Delivery.
Journal of visualized experiments : JoVE. [DOI] 10.3791/62645. [PMID] 34459821.
2021
Staphylococcus pseudintermedius Bacteremia in a Lung Transplant Recipient Exposed to Domestic Pets.
Cureus. [DOI] 10.7759/cureus.14895. [PMID] 34109083.
2020
Tetravalent dengue DNA vaccine is not immunogenic when delivered by retrograde infusion into salivary glands
Tropical Diseases, Travel Medicine and Vaccines. [DOI] 10.1186/s40794-020-00111-5. [PMID] 32518668.
2019
<p>Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review</p>
Infection and Drug Resistance. [DOI] 10.2147/idr.s180908.
2019
Cryptococcus neoformans pericarditis in a lung transplant recipient: Case report, literature review and pearls
Transplant Infectious Disease. [DOI] 10.1111/tid.13137.
2019

Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review

Infection and Drug Resistance. [DOI] 10.2147/idr.s180908.
2019
Safety considerations with current and emerging antiviral therapies for cytomegalovirus infection in transplantation
Expert Opinion on Drug Safety. [DOI] 10.1080/14740338.2019.1662787.
2018
Double invasive fungal infection due to dematiaceous moulds in a renal transplant patient
BMJ Case Reports. [DOI] 10.1136/bcr-2017-222527. [PMID] 29437770.
2017
Candida pararugosa: First Reported Bloodstream Infection in an Adult.
Cureus. [DOI] 10.7759/cureus.1283. [PMID] 28680771.

Contact Details

Phones:
Business:
(352) 294-5481
Emails:
Addresses:
Business Mailing:
PO Box 100289
PO Box 100289
GAINESVILLE FL 32610